{"id":7064920,"date":"2026-09-23T16:00:44","date_gmt":"2026-09-23T16:00:44","guid":{"rendered":"https:\/\/som2nypost.com\/uncategorized\/qc-healthcare-and-sanguina-collaborate-for-ai-blood-health-tools\/"},"modified":"2026-09-23T16:00:44","modified_gmt":"2026-09-23T16:00:44","slug":"qc-healthcare-and-sanguina-collaborate-for-ai-blood-health-tools","status":"publish","type":"post","link":"https:\/\/som2nypost.com\/?p=7064920","title":{"rendered":"QC Healthcare and Sanguina collaborate for AI blood health tools"},"content":{"rendered":"


\n<\/p>\n

\n
\n
\n \"\"\/\n <\/picture>
The trial aims to assess biological and clinical activity of TTX-MC138 in patients with MRD. Credit: Pickadook \/ Shutterstock.com.<\/figcaption><\/figure>\n<\/p><\/div>\n

QC Healthcare has entered a collaboration with Sanguina to implement AI-based blood health technologies across its digital healthcare platforms in the US.<\/p>\n

The agreement will see Sanguina\u2019s non-invasive screening tools, which use fingernail analysis to provide insights on blood health, integrated into QC Healthcare\u2019s network of virtual care services.<\/p>\n

\n
\n
\"\"\/<\/figure>\n

Discover B2B Marketing That Performs <\/h4>\n

\n\t\t\t\t\t\tCombine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.\n\t\t\t\t\t<\/p>\n


\n\t\t\t\t\t\t\tFind out more <\/default:svg><\/span><\/a><\/p>\n<\/section>\n<\/div>\n

The initial phase of the partnership will focus on the My Pediatric Doctor and My Adult Doctor telehealth services, which provide 24\/7 urgent and primary care nationwide.<\/p>\n

QC Healthcare and Sanguina plan to extend these capabilities to other platforms, including My Oncology Doctor and My VA Doctor, at a later stage.<\/p>\n

Sanguina\u2019s technology enables screening for anaemia and circulatory concerns by using videos of patients\u2019 fingernails to gather digital biomarkers.<\/p>\n

The Circulation Score generated by this tool measures the speed at which blood returns to the fingertips after pressure is released, a process clinicians have traditionally performed at the bedside to assess peripheral perfusion.<\/p>\n

Delivered remotely, this scoring system offers additional information to telehealth practitioners during patient assessments, but is not intended as a standalone diagnostic tool or substitute for laboratory results, physical examination, or emergency care.<\/p>\n

By embedding these AI-driven tools in its digital workflows, QC Healthcare expects to help identify potential health issues related to blood earlier in patients and streamline their connection to appropriate clinical care options.<\/p>\n

QC Healthcare CEO Eric Doherty said: \u201cThis collaboration represents the future direction of healthcare\u2014moving from reactive treatment toward earlier identification, informed follow-up, and prevention.<\/p>\n

\u201cBy combining QC Healthcare\u2019s nationwide virtual care ecosystem with Sanguina\u2019s innovative AI technology, we can help bring meaningful blood-health information into the home and connect it to licensed clinical care.<\/p>\n

\u201cThat opportunity extends across the families served by My Paediatric Doctor and My Adult Doctor today, as well as pregnant and postpartum women, veterans, and people navigating cancer who may benefit from the future My VA Doctor and My Oncology Doctor platforms.\u201d<\/p>\n

The deployment of these screening features in My Pediatric Doctor and My Adult Doctor will be followed by consideration of further integration into other QC Healthcare services.<\/p>\n

<\/p>\n

<\/p>\n

\n